AVXL
ANAVEX LIFE SCIENCES CORP.
Key Financials
Operating Income
$-51408000
↑ 2.8%
Net Income
$-46377000
↓ 7.8%
EPS (Diluted)
$-0.54
↓ 3.8%
Total Liabilities
$8.9M
↓ 41.5%
Total Assets
$103.8M
↓ 23.4%
Cash & Equivalents
$102.6M
↓ 22.4%
Shareholders' Equity
$94.9M
↓ 21.1%
Operating Cash Flow
$-39044000.00
↓ 26.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/28/2026 | View on SEC |
| 8-K | 9/28/2026 | View on SEC |
| DFAN14A | 9/21/2026 | View on SEC |
| DFAN14A | 9/18/2026 | View on SEC |
| DFAN14A | 9/17/2026 | View on SEC |
| DEFA14A | 9/15/2026 | View on SEC |
| DFAN14A | 9/15/2026 | View on SEC |
| DEFA14A | 9/14/2026 | View on SEC |
| DFAN14A | 9/10/2026 | View on SEC |
| DFAN14A | 9/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AVXL |
| Company Name | ANAVEX LIFE SCIENCES CORP. |
| CIK | 1314052 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| Phone | 844-689-3939 |